Katelyn Jison Yoo
Katelyn Jison Yoo has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
David Bishai
Johns Hopkins Bloomberg School of Public Health, USA
4 shared publicationsBryan Patenaude
Johns Hopkins Bloomberg School of Public Health, USA
2 shared publications- Neil W. Schluger
New York Medical College, Valhalla, New York, USA
2 shared publications - Sooyeol Park
University of North Carolina at Chapel Hill, USA
2 shared publications Taejin Lee
Seoul National University, South Korea
2 shared publicationsYoonkyoung Lee
Seoul National University, South Korea
2 shared publications
Latest Publications
- 10 August 2026
- Published by BMJ in Tobacco Control
Illusion of choice: re-evaluating nicotine addiction in the Korean legal landscape
- 10 August 2026
- Published by BMJ in Tobacco Control
Illusion of choice: re-evaluating nicotine addiction in the Korean legal landscape
- Open Access
- 1 May 2026
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 70
The toll of tobacco: smoking-attributable health spending in South Korea, 2014–2024. National claims evidence for cost recovery
- 1 May 2026
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 70
Open AccessThe toll of tobacco: smoking-attributable health spending in South Korea, 2014–2024. National claims evidence for cost recovery
- Open Access
- 5 August 2025
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 61, 101655
NHIS vs. Big Tobacco: South Korea’s pursuit of cost recovery through litigation
- 5 August 2025
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 61, 101655
Open AccessNHIS vs. Big Tobacco: South Korea’s pursuit of cost recovery through litigation
- Open Access
- 30 December 2024
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 54, 101269
South Korea’s healthcare expenditure: a comprehensive study of public and private spending across health conditions, demographics, and payer types (2011–2020)
- 30 December 2024
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 54, 101269
Open AccessSouth Korea’s healthcare expenditure: a comprehensive study of public and private spending across health conditions, demographics, and payer types (2011–2020)
- Open Access
- 28 October 2024
- Published by Cambridge University Press (CUP) in Disaster Medicine and Public Health Preparedness
- Vol. 18, e217
Illustrating the Anticipate, Recruit, Retain, Adapt, Sustain (ARRAS) Framework for Surge Capacity. How Bangladesh, Sri Lanka, and Nepal Maintained Their Health Workforce During COVID-19
Surge capacity—the ability to acquire additional workers and resources during unexpected increases in service demand—is often perceived as a luxury. However, the COVID-19 pandemic necessitated an urgent expansion of surge capacity within health systems globally. Health systems in Bangladesh, Nepal, and Sri Lanka managed to scale up their capacities despite severely limited budgets. This study employs a mixed-methods approach, integrating qualitative interviews with quantitative data analysis, to propose a comprehensive framework for understanding Human Resources for Health (HRH) surge capacity from 2018 to 2021, termed ARRAS: Anticipate, Recruit, Retain, Adapt, Sustain. We present national-level data to demonstrate how each country was able to maintain their per capita health care workforce during the crisis. Interviews with key informants from each country reinforce the ARRAS framework. Quantitative data revealed ongoing increases in doctors and nurses pre- and post-pandemic, but no country could rapidly expand its health workforce during the crisis. Qualitative findings highlighted critical strategies such as pre-crisis planning, financial incentives, telemedicine, and re-skilling the workforce. Despite adaptive measures, challenges included inadequate funding, poor data systems, and coordination issues. This study underscores the necessity for robust, long-term strategies to enhance surge capacity and better prepare health systems for future crises.
- 28 October 2024
- Published by Cambridge University Press (CUP) in Disaster Medicine and Public Health Preparedness
- Vol. 18, e217
Open AccessIllustrating the Anticipate, Recruit, Retain, Adapt, Sustain (ARRAS) Framework for Surge Capacity. How Bangladesh, Sri Lanka, and Nepal Maintained Their Health Workforce During COVID-19
Surge capacity—the ability to acquire additional workers and resources during unexpected increases in service demand—is often perceived as a luxury. However, the COVID-19 pandemic necessitated an urgent expansion of surge capacity within health systems globally. Health systems in Bangladesh, Nepal, and Sri Lanka managed to scale up their capacities despite severely limited budgets. This study employs a mixed-methods approach, integrating qualitative interviews with quantitative data analysis, to propose a comprehensive framework for understanding Human Resources for Health (HRH) surge capacity from 2018 to 2021, termed ARRAS: Anticipate, Recruit, Retain, Adapt, Sustain. We present national-level data to demonstrate how each country was able to maintain their per capita health care workforce during the crisis. Interviews with key informants from each country reinforce the ARRAS framework. Quantitative data revealed ongoing increases in doctors and nurses pre- and post-pandemic, but no country could rapidly expand its health workforce during the crisis. Qualitative findings highlighted critical strategies such as pre-crisis planning, financial incentives, telemedicine, and re-skilling the workforce. Despite adaptive measures, challenges included inadequate funding, poor data systems, and coordination issues. This study underscores the necessity for robust, long-term strategies to enhance surge capacity and better prepare health systems for future crises.
- Open Access
- 11 March 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 70, 102524
Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010–22: a modelling study
- 11 March 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 70, 102524
Open AccessEquity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010–22: a modelling study
- Open Access
- 21 September 2023
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 41, 100904
The road to recovery: impact of COVID-19 on healthcare utilization in South Korea in 2016–2022 using an interrupted time-series analysis
- 21 September 2023
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 41, 100904
Open AccessThe road to recovery: impact of COVID-19 on healthcare utilization in South Korea in 2016–2022 using an interrupted time-series analysis
- Open Access
- 1 May 2022
- Published by WHO Press
- Vol. 100 (05) , 315-328
COVAX and equitable access to COVID-19 vaccines
To evaluate equity in the allocation and distribution of vaccines for coronavirus disease 2019 (COVID-19) to countries and territories participating in the COVID-19 Vaccines Global Access (COVAX) Facility. We used publicly available data on the numbers of COVAX vaccine doses allocated and distributed to 88 countries and territories qualifying for COVAX-sponsored vaccine doses and 60 countries self-financing their vaccine doses facilitated by COVAX. We conducted a benefit–incident analysis to examine the allocation and distribution of vaccines based on countries’ gross domestic product (GDP) per capita. We plotted cumulative country-level per capita allocation and distribution of COVID-19 vaccines from COVAX against the ranked per capita GDP of the countries and territories to generate a measure of the equity of COVAX benefits. By 23 January 2022 the COVAX Facility had allocated a total of 1 678 517 990 COVID-19 vaccine doses, of which 1 028 291 430 (61%) doses were distributed to 148 countries and territories. Taking account of COVAX subsidies, we found that countries and territories with low per capita GDP benefited more than higher-income countries in the numbers of vaccines. The benefits increased further when the analysis was adjusted by population age group (aged 65 years and older). The COVAX Facility is helping to balance global inequities in the allocation and distribution of COVID-19 vaccines. However, COVAX alone has not been enough to reverse the inequality of total COVID-19 vaccine distribution. Future studies could examine the equity of all COVID-19 vaccine allocation and distribution beyond the COVAX-facilitated vaccines.
- 1 May 2022
- Published by WHO Press
- Vol. 100 (05) , 315-328
Open AccessCOVAX and equitable access to COVID-19 vaccines
To evaluate equity in the allocation and distribution of vaccines for coronavirus disease 2019 (COVID-19) to countries and territories participating in the COVID-19 Vaccines Global Access (COVAX) Facility. We used publicly available data on the numbers of COVAX vaccine doses allocated and distributed to 88 countries and territories qualifying for COVAX-sponsored vaccine doses and 60 countries self-financing their vaccine doses facilitated by COVAX. We conducted a benefit–incident analysis to examine the allocation and distribution of vaccines based on countries’ gross domestic product (GDP) per capita. We plotted cumulative country-level per capita allocation and distribution of COVID-19 vaccines from COVAX against the ranked per capita GDP of the countries and territories to generate a measure of the equity of COVAX benefits. By 23 January 2022 the COVAX Facility had allocated a total of 1 678 517 990 COVID-19 vaccine doses, of which 1 028 291 430 (61%) doses were distributed to 148 countries and territories. Taking account of COVAX subsidies, we found that countries and territories with low per capita GDP benefited more than higher-income countries in the numbers of vaccines. The benefits increased further when the analysis was adjusted by population age group (aged 65 years and older). The COVAX Facility is helping to balance global inequities in the allocation and distribution of COVID-19 vaccines. However, COVAX alone has not been enough to reverse the inequality of total COVID-19 vaccine distribution. Future studies could examine the equity of all COVID-19 vaccine allocation and distribution beyond the COVAX-facilitated vaccines.
- Top Cited Papers
- 1 May 2021
- Published by Elsevier in Health Policy
- Vol. 125 (5) , 568-576
Systematic assessment of South Korea’s capabilities to control COVID-19
- 1 May 2021
- Published by Elsevier in Health Policy
- Vol. 125 (5) , 568-576
Top Cited PapersSystematic assessment of South Korea’s capabilities to control COVID-19